A growing number of informal caregivers (IFCs) manage hospice patients’ anxiety by administering lorazepam (Ativan), yet little is known about prescribing practices in home care or the extent to which IFCs carry out regimens.
Design and Methods:
Data on hospice prescribed lorazepam was determined through a retrospective review of medication records from 216 deceased patients. The dose of lorazepam and type of regimen (i.e., scheduled, PRN, combination) as well as frequency with which it was administered by IFCs was calculated upon admission to a residential care home and on patients’ day of death.
Results:
The majority (63.1%) of patients were prescribed lorazepam on admission to the home, and more (79.5%) were prescribed lorazepam on the day of death. While higher doses of lorazepam were prescribed and administered on the day of death, the percentage of medication consumed was low on admission (17%) and day of death (27%). Nearly all (92.8%) prescribed lorazepam on the day of death were allowed PRN medication. For PRN only regimens, less than a quarter (24.4%) of patients were given lorazepam on admission with less than half (40.4%) given it while dying. Highest lorazepam administration rates (91.2%) occurred on the day of death when lorazepam was prescribed under a combined regimen.
Conclusion:
The high frequency of PRN regimens reveal that IFCs are frequently tasked with making decisions about if and when to administer lorazepam. Low overall lorazepam administration suggests a closer monitoring of lorazepam use and enhanced support of IFCs may be needed.
KozlovEPhongtankuelVPrigersonH, et al.Prevalence, severity, and correlates of symptoms of anxiety and depression at the very end of life. J Pain Symptom Manag. 2019;58(1):80–85. https://search.datacite.org/works/10.1016./j.jpainsymman.2019.04.012. doi:10.1016/j.jpainsymman.2019.04.012
2.
TangSTChenJChouW, et al.Longitudinal analysis of severe anxiety symptoms in the last year of life among patients with advanced cancer: relationships with proximity to death, burden, and social support. J Natl Compr Canc Netw. 2016;14(6):727–734. https://www.ncbi.nlm.nih.gov/pubmed/27283165. doi:10.6004/jnccn.2016.0074
3.
FordJA. The complexity of assessment and treatment for anxiety in patients with a terminal illness. J Hosp Palliat Nurs. 2016;18(2):131–138. doi:10.1097/NJH.0000000000000223
4.
ZweersDde GraafETeunissenS. Suitable support for anxious hospice patients: what do nurses ‘know’, ‘do’ and ‘need’? An explanatory mixed method study. BMJ Support Palliat Care. 2020;10(2):e15. https://dx-doi-org.web.bisu.edu.cn/10.1136/bmjspcare-2016-001187. doi:10.1136/bmjspcare-2016-001187
5.
AtkinNVickerstaffVCandyB. ‘Worried to death’: the assessment and management of anxiety in patients with advanced life-limiting disease, a national survey of palliative medicine physicians. BMC Palliat Care. 2017;16(1):69. https://www.ncbi.nlm.nih.gov/pubmed/29224571. doi:10.1186/s12904-017-0245-5
6.
AldridgeMCanavanMCherlinEBradleyE. Has hospice use changed? 2000–2010 utilization patterns. Med Care. 2015;53(1):95–101. https://www.ncbi.nlm.nih.gov/pubmed/25373406. doi:10.1097/MLR.0000000000000256
KamellASmithLK. Attitudes toward use of benzodiazepines among U.S. hospice clinicians: survey and review of the literature. J Palliat Med. 2016;19(5):516–522. https://www.liebertpub.com/doi/abs/10.1089/jpm.2015.0376. doi:10.1089/jpm.2015.0376
9.
ElsayemACurryIII EBooheneJ, et al.Use of palliative sedation for intractable symptoms in the palliative care unit of a comprehensive cancer center. Support Care Cancer. 2009;17(1):53–59. https://www.ncbi.nlm.nih.gov/pubmed/18461370. doi:10.1007/s00520-008-0459-4
10.
AdvokatCDComatyJEJulienRM. Julien’s Primer of Drug Action. 13. Worth Publishers; 2014.
CampbellCLKellyMRovnyakV. Pain management in home hospice patients: a retrospective descriptive study. Nurs Health Sci. 2017;19(3):381–387. doi:10.1111/nhs.12359
15.
PayneSTurnerMSeamarkD, et al.Managing end of life medications at home—accounts of bereaved family carers: a qualitative interview study. BMJ Support Palliat Care. 2015;5(2):181–188.
16.
TjiaJEllingtonLClaytonMFLemayCReblinM. Managing medications during home hospice cancer care: the needs of family caregivers. J Pain Symptom Manage. 2015;50(5):630–641. https://www.clinicalkey.es/playcontent/1-s2.0-S088539241500322X. doi:10.1016/j.jpainsymman.2015.06.005
17.
McNeilMJKamalAHKunterJSRitchieCSAbernethyAP. The burden of polypharmacy in patients near the end of life. J. Pain Symptom Manage. 2016;51:178–183.
18.
VaismoradiMAmaniyanSJordanS. Patient safety and pro re nata prescription and administration: a systematic review. Pharmacy (Basel). 2018;6(3):95. doi:10.3390/pharmacy6030095
19.
ArevaloJJGeijtemanEHuismanB, et al.Medication use in the last days of life in hospital, hospice, and home settings in the Netherlands. J Palliat Med. 2018;21(2):149–155. doi:10.1089/jpm.2017.0179
20.
MayaharaMPaiceJWilburJFoggLForemanM. Common errors in using analgesics by home-based nonprofessional hospice caregivers. J Hospice Palliat Nurs. 2014;16(3):134–140. doi:10.1097/NJH.0000000000000040
21.
JoyceBTLauDT. Hospice experiences and approaches to support and assess family caregivers in managing medications for home hospice patients: a providers survey. Palliat Med. 2013;27(4):329–338. https://journals.sagepub.com/doi/full/10.1177/0269216312465650. doi:10.1177/0269216312465650
22.
LauDTBermanRHalpernLPickardASSchraufRWittW. Exploring factors that influence informal caregiving medication management for home hospice patients. J Palliat Med. 2010;13(9):1085–1090. doi:10.1089/jpm.2010.0082
23.
Sheehy-SkeffingtonBMcLeanSBramwellMO’LearyNO’GormanA. Caregivers experiences of managing medications for palliative care patients at the end of life. Am J Hosp Palliat Med. 2014;31(2):148–154. https://journals.sagepub.com/doi/full/10.1177/1049909113482514. doi:10.1177/1049909113482514
24.
SpeerNDDiosoJCasnerPR. Costs and implications of discarded medication in hospice. J Palliat Med. 2013;16(8):975–978. doi:10.1089/jpm.2013.0095
25.
GrantHScottK. An introduction and overview of social model hospice care. J Hosp Palliat Nurs. 2015;17(5):456–461.
26.
SmithJOnaFV. Mt Carmel House: a home for terminally ill patients who cannot go home. Cancer Invest. 1995;13(2):239–243.
OliverDPWittenberg-LylesEWashingtonK, et al.Hospice caregivers’ experiences with pain management: “I’m not a doctor, and I don’t know if I helped her go faster or slower”. J Pain Symptom Manage. 2013;46(6):846–858. doi:10.1016/j.jpainsymman.2013.02.011
PhongtankuelVScherbanBAReidMC, et al.Why do home hospice patients return to the hospital? A study of hospice provider perspectives. J Palliat Med. 2016;19(1):51–56. https://www.liebertpub.com/doi/abs/10.1089/jpm.2015.0178. doi:10.1089/jpm.2015.0178
